HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc. (NRXP), Monday announced the acquisition of a strategic interest in Cohen and Associates, LLC and its incorporation into the HOPE Network.
Additionally, the company announced that Rebecca Cohen has joined HOPE as Medical Director.
"Together with HOPE's leadership, we aim to remain on the cutting edge of life transforming therapy for depression and PTSD and to rapidly expand to change the lives of the 13 million Americans who tragically contemplate suicide each year," said Dr. Cohen.
Currently, NRXP is trading at $3.12, down 1.88 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.